By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Announces Promotion Of Michael D. Becker To Chief Financial Officer 5/16/2016 6:52:41 AM
Relmada Therapeutics Announces Results Of In Vivo Study Showing d-Methadone Has Antidepressant-like Effects 5/4/2016 6:52:23 AM
Relmada Therapeutics To Present At The Joseph Gunnar "Pioneers 2016" Conference 4/28/2016 9:53:19 AM
Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day 4/26/2016 10:18:32 AM
Relmada Therapeutics To Showcase Breadth Of Pipeline At Upcoming R&D Day 4/20/2016 8:05:25 AM
Relmada Therapeutics Provides Update On Nasdaq Up-Listing Process 4/14/2016 7:24:22 AM
Relmada Therapeutics To Present At The 28th Annual ROTH Conference 3/8/2016 7:59:16 AM
Relmada Therapeutics Announces Publication Of Full Results From Phase I Study Showing Treatment With D-Methadone To Be Safe And Well Tolerated 3/1/2016 6:12:40 AM
Relmada Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 9:04:40 AM
Relmada Therapeutics Files Amended Complaint Against Laidlaw And Its Principals, Matthew Eitner And James Ahern 1/26/2016 6:19:37 AM